Prostate Cancer
Recent Abstracts
Adipose triglyceride lipase is a therapeutic target in advanced prostate cancer that promotes metabolic plasticity.
December 5, 2023
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial.
December 5, 2023
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI.
December 5, 2023
Early response monitoring during [177Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study.
December 5, 2023
Elective Nodal Irradiation for Oligorecurrent Nodal Prostate Cancer: Interobserver Variability in the PEACE V-STORM Randomized Phase 2 Trial.
December 5, 2023
Research protocol to identify progression and death amongst patients with metastatic hormone-sensitive prostate cancer treated with available treatments: PIONEER IMI's "big data for better outcomes" program.
December 5, 2023
Phenotype plasticity and altered sensitivity to chemotherapeutic agents in aggressive prostate cancer cells.
December 5, 2023
Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.
December 4, 2023
Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancer.
December 4, 2023
Population-based Organised Prostate Cancer Testing: Results from the First Invitation of 50-year-old Men.
December 4, 2023
Prediction models of incontinence and sexual function one year after radical prostatectomy based on data from 20 164 prostate cancer patients.
December 4, 2023
Comparison of Urinary Diversion in Patients with Prostatic Fistula to Those with Localized Radiation Injury after Radiotherapy for the Treatment of Prostate Cancer.
December 4, 2023
Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high-risk localized prostate cancer.
December 4, 2023
UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistance.
December 4, 2023
Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells.
December 4, 2023
First Patient with Metastatic Prostate Cancer to Receive 2 Doses of Cu-67 SAR-bisPSMA Achieves Undetectable PSA Level
December 1, 2023
Registrational Phase III CLARIFY Trial in Prostate Cancer Commences
December 1, 2023
Clinical outcomes for men with positive surgical margins after radical prostatectomy-results from the South Australian Prostate Cancer Clinical Outcomes Collaborative community-based registry.
December 1, 2023
Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial.
December 1, 2023
Glucocorticoid receptor (GR) activation is associated with increased cAMP/PKA signaling in castrate-resistant prostate cancer.
December 1, 2023
Page 64 of 1414
Start
Prev
59
60
61
62
63
64
65
66
67
68
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free